DNAH8-AS1

Across TCGA pan-cancer cohorts, DNAH8-AS1 RNA is linked to patient survival in 15 of 34 cancer types, making it the most broadly survival-associated DNAH8-AS1 data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher DNAH8-AS1 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated DNAH8-AS1 expression acts as an unfavorable survival marker, although some lineages such as BLCA and LUAD show a favorable association.

BLCA, ACC, and KICH are the cancer types where DNAH8-AS1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	DFS	Median	III,IV	0.599	0.374	<.001	125	view →
ACC	DFS	Tertile	III,IV	0.010	0.364	<.001	108	view →
KICH	DFS	Tertile	All	0.429	0.914	<.001	87	view →
KIRC	OS	Tertile	All	0.555	0.730	<.001	70	view →
LUAD	OS	Quartile	All	0.791	0.607	<.001	58	view →
ESCA	DFS	Tertile	III,IV	0.549	0.240	.004	42	view →
BRCA	OS	Median	III,IV	0.722	0.444	.001	40	view →
OV	OS	Tertile	III,IV	0.386	0.284	.020	38	view →
CHOL	DFS	Tertile	All	1.000	0.266	.015	27	view →
LUSC	DFS	Quartile	III,IV	0.580	0.241	.007	16	view →
SKCM	DFS	Median	IV	0.763	0.187	.006	11	view →
PAAD	OS	Tertile	II,III,IV	0.687	0.512	.017	10	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 15 lineages.

DNAH8-AS1–BLCA (DFS)

Open the BLCA breakdown →